Although microRNAs are also reported to affect NOX2 expression in the heart75 and could be exploited to protect against NOX2-driven adverse effects after myocardial infarction,76 the effect on metabolic cardiac disease is not known. This evidence concerns the gene CYBB and myocardial infarction.